These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 28039911

  • 1. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
    Frommeyer G, Sterneberg M, Dechering DG, Kaese S, Bögeholz N, Pott C, Fehr M, Bogossian H, Milberg P, Eckardt L.
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
    [Abstract] [Full Text] [Related]

  • 2. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
    He Z, Sun C, Xu Y, Cheng D.
    Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
    [Abstract] [Full Text] [Related]

  • 3. Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
    Frommeyer G, Sterneberg M, Dechering DG, Ellermann C, Bögeholz N, Kochhäuser S, Pott C, Fehr M, Eckardt L.
    Int J Cardiol; 2017 Jun 01; 236():237-243. PubMed ID: 28262346
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P, Frommeyer G, Ghezelbash S, Rajamani S, Osada N, Razvan R, Belardinelli L, Breithardt G, Eckardt L.
    Europace; 2013 May 01; 15(5):761-9. PubMed ID: 23376977
    [Abstract] [Full Text] [Related]

  • 6. Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.
    Frommeyer G, Schmidt M, Clauß C, Kaese S, Stypmann J, Pott C, Eckardt L, Milberg P.
    Eur J Heart Fail; 2012 Dec 01; 14(12):1322-31. PubMed ID: 23099358
    [Abstract] [Full Text] [Related]

  • 7. Action Potential Triangulation Explains Acute Proarrhythmic Effect of Aliskiren in a Whole-Heart Model of Atrial Fibrillation.
    Ellermann C, Mittelstedt A, Wolfes J, Willy K, Leitz P, Reinke F, Eckardt L, Frommeyer G.
    Cardiovasc Toxicol; 2020 Feb 01; 20(1):49-57. PubMed ID: 31175534
    [Abstract] [Full Text] [Related]

  • 8. Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model.
    Frommeyer G, Kohnke A, Ellermann C, Dechering DG, Kochhäuser S, Reinke F, Fehr M, Eckardt L.
    Int J Cardiol; 2017 Jun 01; 236():423-426. PubMed ID: 28132779
    [Abstract] [Full Text] [Related]

  • 9. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 01; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 10. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G, Milberg P, Uphaus T, Kaiser D, Kaese S, Breithardt G, Eckardt L.
    Cardiovasc Ther; 2013 Dec 01; 31(6):e63-71. PubMed ID: 23647657
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C, Sterneberg M, Kochhäuser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G.
    Europace; 2018 Oct 01; 20(10):1699-1706. PubMed ID: 29377987
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
    Diness JG, Sørensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, Hansen RS.
    Circ Arrhythm Electrophysiol; 2010 Aug 01; 3(4):380-90. PubMed ID: 20562443
    [Abstract] [Full Text] [Related]

  • 13. Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.
    Ellermann C, Kohnke A, Dechering DG, Kochhäuser S, Reinke F, Fehr M, Eckardt L, Frommeyer G.
    Pharmacology; 2018 Aug 01; 102(3-4):138-141. PubMed ID: 29982246
    [Abstract] [Full Text] [Related]

  • 14. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
    Aidonidis I, Doulas K, Hatziefthimiou A, Tagarakis G, Simopoulos V, Rizos I, Tsilimingas N, Molyvdas PA.
    J Cardiovasc Pharmacol Ther; 2013 Jan 01; 18(1):94-101. PubMed ID: 22872232
    [Abstract] [Full Text] [Related]

  • 15. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
    Hesselkilde EZ, Carstensen H, Haugaard MM, Carlson J, Pehrson S, Jespersen T, Buhl R, Platonov PG.
    BMC Cardiovasc Disord; 2017 Dec 08; 17(1):289. PubMed ID: 29221440
    [Abstract] [Full Text] [Related]

  • 16. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G, Garthmann J, Ellermann C, Dechering DG, Kochhäuser S, Reinke F, Köbe J, Wasmer K, Eckardt L.
    Europace; 2018 Aug 01; 20(8):1375-1381. PubMed ID: 29016765
    [Abstract] [Full Text] [Related]

  • 17. Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
    Farkowski MM, Maciag A, Kowalik I, Konka M, Szwed H, Pytkowski M.
    Br J Clin Pharmacol; 2019 Jul 01; 85(7):1552-1558. PubMed ID: 30920001
    [Abstract] [Full Text] [Related]

  • 18. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G, Rajamani S, Grundmann F, Stypmann J, Osada N, Breithardt G, Belardinelli L, Eckardt L, Milberg P.
    J Card Fail; 2012 Dec 01; 18(12):939-49. PubMed ID: 23207083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Verapamil prevents stretch-induced shortening of atrial effective refractory period in langendorff-perfused rabbit heart.
    Zarse M, Stellbrink C, Athanatou E, Robert J, Schotten U, Hanrath P.
    J Cardiovasc Electrophysiol; 2001 Jan 01; 12(1):85-92. PubMed ID: 11204090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.